{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:27:06Z","timestamp":1757543226650},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"vor","delay-in-days":99,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ijid.2013.05.003","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T21:46:17Z","timestamp":1372455977000},"page":"e907-e912","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis"],"prefix":"10.1016","volume":"17","author":[{"given":"C.","family":"Wejse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Camara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"L\u00fcneborg-Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sodemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gerstoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.L.","family":"Katzenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2013.05.003_bib0005","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1164\/rccm.200804-567OC","article-title":"Vitamin D as supplementary treatment for tuberculosis\u2014a double-blind randomized placebo-controlled trial","volume":"179","author":"Wejse","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2013.05.003_bib0010","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijid.2013.05.003_bib0015","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.157.3.1271","article-title":"Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation","volume":"157","author":"Goletti","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2013.05.003_bib0020","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/00002030-199907090-00002","article-title":"Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology","volume":"13","author":"Del","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.05.003_bib0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-200201040-00010","article-title":"Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy","volume":"16","author":"Dean","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.05.003_bib0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jmv.20257","article-title":"Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d\u2019Ivoire","volume":"75","author":"Kalou","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2013.05.003_bib0035","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1086\/375346","article-title":"Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients","volume":"187","author":"Morris","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.05.003_bib0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/QAI.0b013e31817e9fb4","article-title":"Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis","volume":"49","author":"Srikantiah","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2013.05.003_bib0045","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1097\/00002030-199911120-00005","article-title":"Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans","volume":"13","author":"Lawn","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.05.003_bib0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/QAI.0b013e31817dc3d1","article-title":"p24 as a predictor of mortality in a cohort of HIV-1-infected adults in rural Africa","volume":"48","author":"Erikstrup","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2013.05.003_bib0055","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1590\/S1413-86702008000600008","article-title":"CD4+ cell counts in patients with different clinical manifestations of tuberculosis","volume":"12","author":"Davoudi","year":"2008","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijid.2013.05.003_bib0060","first-page":"98","article-title":"B-lymphocytes and co-stimulatory molecules in Mycobacterium tuberculosis infection","volume":"8","author":"Corominas","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2013.05.003_bib0065","first-page":"261","article-title":"CD4+ T-lymphocytopenia in pulmonary tuberculosis","volume":"2","author":"Grange","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2013.05.003_bib0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2334-12-66","article-title":"CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection","volume":"12","author":"Andersen","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2013.05.003_bib0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/ije\/dyh026","article-title":"Tuberculosis in Bissau: incidence and risk factors in an urban community in sub-Saharan Africa","volume":"33","author":"Gustafson","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ijid.2013.05.003_bib0080","series-title":"TB\/HIV: a clinical manual","first-page":"49","author":"Harries","year":"2004"},{"key":"10.1016\/j.ijid.2013.05.003_bib0085","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/CDLI.12.11.1298-1304.2005","article-title":"Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects","volume":"12","author":"Kizza","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.ijid.2013.05.003_bib0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/00365540701558698","article-title":"TBscore: signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course","volume":"40","author":"Wejse","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijid.2013.05.003_bib0095","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jmv.20655","article-title":"Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART","volume":"78","author":"Sch\u00fcpbach","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2013.05.003_bib0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.trstmh.2005.07.018","article-title":"Kinetics of sedimentation rate, viral load and TNF-alpha in relation to HIV co-infection in tuberculosis","volume":"100","author":"Schon","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2013.05.003_bib0105","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1086\/424851","article-title":"Does tuberculosis increase HIV load?","volume":"190","author":"Day","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.05.003_bib0110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1006\/viro.1999.9867","article-title":"Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-Bissau with single or dual infections: predominance of a distinct HIV-1 subtype A\/G recombinant in West Africa","volume":"262","author":"Andersson","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.ijid.2013.05.003_bib0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0166-0934(03)00219-2","article-title":"Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals","volume":"113","author":"Ribas","year":"2003","journal-title":"J Virol Methods"},{"key":"10.1016\/j.ijid.2013.05.003_bib0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0924-8579(00)00272-7","article-title":"Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure","volume":"16","author":"Schupbach","year":"2000","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971213001975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971213001975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T19:01:11Z","timestamp":1688324471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971213001975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1201971213001975"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2013.05.003","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2013.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}